Editorial on Market Analysis Report of Radiology
Radiology is the term used for the treatment of cancer. The doctor who specializes in the Radiation Therapy is known as Radiologist. The vital role of the Radiologist is to diagnose the people who are suffering from cancer and explain the adverse effects during the treatment. There are different types of Radiologists in treating cancer. This field of Radiology and its market is growing rapidly and its development is making an amazing impact in medical and health sciences and pharmaceuticals. The importance and significance can be calculated by the fact that it had made great advancements over the period of time and is continuing in various other sectors. Research and development in Radiology addresses wide range of topics such as, neural processes underlying visually guided behavior, comparative anatomy and physiology of human systems, development of the cancerous drugs, regenerative medicine in Cancer therapy science, photoreceptor function to neuronal consciousness and awareness, diagnosis and treatment of cancer, machine and computational therapy. Cancer is a major issue worldwide and 14.1 million people are estimated to be affected by cancer worldwide out of which 8.2 million have died. Globally improper diagnosis are the main cause of moderate and severe Cancers; Tobacco remains the leading cause of Cancer in developed countries; Alcohol & others things are also leading causes of Cancer. Cancer is a common term for a large group of diseases that can affect any organ of the body. Other terms used are malignant tumors and neoplasms. One of the significant features of cancer is the rapid creation of abnormal cells that grow beyond their usual margins, and which can then attack the adjoining parts of the body and spread to other organs. This process is referred to as metastasis. They are the major cause of death from cancer.Tobacco use, alcohol use, unhealthy diet and physical inactivity are the main cancer risk factors worldwide. Chronic infections from hepatitis B(HBV), hepatitis C virus (HCV) and some types of Kaposi’s sarcoma are leading risk factors for cancer in low- and middle-income countries As there is a rapid growth in patients with Cancer and the cases of tumors and cancers are increasing every year. The worldwide cancer drugs market exceeds $161.30 billion (US) and is growing at more than 28% per year. Without the incorporation of consumer cancer chemotherapy drugs, the cancer products market is roughly an $89 billion market. Cancer drugs revenue was USD 112.90 billion in 2015 and is expected to generate revenue of around USD161.30 billion by end of 2021, growing at a CAGR of around 7.4% between 2016 and 2021. Oncology continues to be an area of active interest with a robust pipeline of over 600 molecules in the late-stage development of which 90% is a targeted therapy.